A fully magnetically levitated circulatory pump for advanced heart failure

New England Journal of Medicine

Volumn 376, Issue 5, 2017, Pages 440-450

  Mehra, Mandeep R ^a   Naka, Yoshifumi ^b   Uriel, Nir ^d   Goldstein, Daniel J ^c   Cleveland, Joseph C ^e   Colombo, Paolo C ^b   Walsh, Mary N ^f   Milano, Carmelo A ^g   Patel, Chetan B ^g   Jorde, Ulrich P ^c   Pagani, Francis D ^h   Aaronson, Keith D ^h   Dean, David A ⁱ   McCants, Kelly ⁱ   Itoh, Akinobu ^j   Ewald, Gregory A ^j   Horstmanshof, Douglas ^k   Long, James W ^k   Salerno, Christopher ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b New York Presbyterian Hospital ^*  (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f St Vincent s Heart Center of Indiana   (United States)

^g DUKE UNIVERSITY   (United States)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

ⁱ PIEDMONT HOSPITAL   (United States)

^j WASHINGTON UNIVERSITY   (United States)

^k INTEGRIS BAPTIST MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; AXIAL CONTINUOUS FLOW PUMP; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; CENTRIFUGAL CONTINUOUS FLOW PUMP; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEVICE INFECTION; DEVICE THERAPY; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; FUNCTIONAL STATUS; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMOLYSIS; HUMAN; KIDNEY DISEASE; LEFT VENTRICULAR ASSIST DEVICE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PUMP; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; REOPERATION; RESPIRATORY FAILURE; SEPSIS; THROMBOSIS; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEART ASSIST DEVICE; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; STROKE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS FAILURE; STROKE; THROMBOSIS; YOUNG ADULT;

EID: 85011890991     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1610426     Document Type: Article

References (18)

1. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-51.
2. Patel CB, Cowger JA, Zuckermann A. A contemporary review of mechanical circulatory support. J Heart Lung Transplant 2014; 33: 667-74.
3. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014; 370: 33-40.
4. Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 2014; 33: 12-22.
5. Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2014; 33: 23-34.
6. Stulak JM, Dunlay SM, Sharma S, et al. Treatment of device thrombus in the HeartWare HVAD: success and outcomes depend significantly on the initial treatment strategy. J Heart Lung Transplant 2015; 34: 1535-41.
7. Stewart GC, Givertz MM, Mehra MR. Pump thrombosis redux. J Heart Lung Transplant 2015; 34: 1511-4.
8. Pagani FD, Aaronson KD, Kormos R, et al. The NHLBI REVIVE-IT Study: understanding its discontinuation in the context of current left ventricular assist device therapy. J Heart Lung Transplant 2016; 35: 1277-83.
9. Schmitto JD, Hanke JS, Rojas SV, Avsar M, Haverich A. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant 2015; 34: 858-60.
10. Heatley G, Sood P, Goldstein D, et al. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J Heart Lung Transplant 2016; 35: 528-36.
11. Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: A multifactorial phenomenon. J Heart Lung Transplant 2014; 33: 51-9.
12. Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in longterm mechanical circulatory support. J Heart Lung Transplant 2014; 33: 1-11.
13. Shah P, Mehta VM, Cowger JA, Aaronson KD, Pagani FD. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant 2014; 33: 102-4.
14. Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: A multicenter study. J Am Coll Cardiol 2015; 66: 2579-89.
15. Netuka I, Kvasnička T, Kvasnička J, et al. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant 2016; 35: 860-7.
16. Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15, 000 patients and counting. J Heart Lung Transplant 2015; 34: 1495-504.
17. Willey JZ, Demmer RT, Takayama H, Colombo PC, Lazar RM. Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: Risk factors, diagnosis, and treatment. J Heart Lung Transplant 2014; 33: 878-87.
18. Teuteberg JJ, Stewart GC, Jessup M, et al. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). JACC Heart Fail 2013; 1: 369-78.